Mbx Capital
Emerging managerBuilt from this firm's Form D filings. The firm files no SEC adviser report.
- Website
- https://mbxcapital.com
- HQ
- DE
Mbx Capital backs the best companies in Deep Health. The firm lists Gurdane Bhutani and Zeshan Muhammedi among its people. Its portfolio includes many companies, such as AmacaThera, Ancilia Bio, Arine, Atlas Health, Attivare Therapeutics, Case45, Catena Biosciences, and Vivodyne.
01 · Says / Does
| Tag | Says | Does |
|---|---|---|
| Stages | Not stated | Not enough dated deals |
| Sectors | Not stated | Not enough dated deals |
| Regions | Not stated | Not enough dated deals |
Says: what the firm's funds state. Does: from 0 dated deals in the last 24 months.
02 · Fund history
| Fund | Year | Size | Status |
|---|---|---|---|
| MBX CAPITAL III, LP MBX Capital backs the best companies in Deep Health, with a portfolio spanning areas such as diagnostics, biosciences, surgical tools, and clinical trial technology. Inferred from the firm's website | approx. 2023 | $50M (Form D) | Open, writing first checks |
| MBX Capital II, LP | approx. 2021 | $30M (Form D) | Follow-ons only |
03 · People across funds
- Gurdane Bhutani, Member and Manager of the General Partner of the Issuer
MBX CAPITAL III, LP (Named on Form D); MBX Capital II, LP (Named on Form D)
- Zeshan Muhammedi, Member and Manager of the General Partner of the Issuer
MBX CAPITAL III, LP (Named on Form D); MBX Capital II, LP (Named on Form D)
04 · Recent deals
No dated deals found yet.
05 · Latest from the firm
No news from the firm's website yet.
06 · Sources
Fund dates and sizes are from SEC Form D filings.
Last verified: Oct 28, 2026